Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 14,455 shares at $27.67 ($394K) on 2021-04-12, disclosed to the SEC on 2021-04-13.
Open-market sale of $394k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.83 | 4,072 | $109K | 27.8% |
| 2 | $26.83 | 4,072 | $109K | 27.8% |
| 3 | $27.67 | 2,883 | $80K | 20.3% |
| 4 | $27.67 | 2,883 | $80K | 20.3% |
| 5 | $28.65 | 545 | $16K | 4.0% |
| Total | $27.23 avg | 14,455 |
| $394K |
| 100% |
| Filing → |
| NRIX | SELL | 2021-06-11 | $220K | — | Filing → |
| NRIX | SELL | 2021-05-11 | $378K | — | Filing → |
| NRIX | SELL | 2021-03-09 | $548K | — | Filing → |